Comparison of Ketorolac at Three Doses in Children With Acute Pain
Status:
Not yet recruiting
Trial end date:
2025-02-01
Target enrollment:
Participant gender:
Summary
Hospital Scene #1: A 6-year-old arrives in the Emergency Department at McMaster Children's
Hospital (MCH) complaining of pain in his lower right side. His Dad explains the pain has
been going on for a few hours and that Advil and Tyelnol haven't helped at all. He's anxious
and concerned about his son because he never complains about pain - so this must be bad.
After he has been seen by the doctor, the appendix appears to be the problem and the boy
needs to have it removed. Dad wants his son's pain to go away but is worried because he once
got a high dose of a medication and had some unwanted side effects.
Hospital Scene #2: A 14-year-old girl has been experiencing migraine headaches for the past
months and is awaiting an appointment with a specialist. Today, however, the pain is the
worst it's been. Mom has picked her up from school and brought her to MCH not knowing what
else to do to help her. The Advil and Tylenol have not improved her pain. She desperately
wants the pain to go away but is worried because she read that some pain medicines are used
without any studies done to see if they work and if they are safe.
(https://www.ottawalife.com/article/most-medications-prescribed-to-children-have-not-been-ade
quately-studied?c=9).
In both cases, these children need medicine to help their pain. The treating doctors want to
give them pain medicine that will 1) be safe and 2) make the pain go away. This is what
parents and the child/teenager, and the doctors want too. Some pain medicines like opioids
are often used to help with pain in children. Unfortunately, opioids can have bad side
effects and can, when used incorrectly or for a long time, be addictive and even dangerous. A
better option would be a non-opioid, like Ketorolac, which also helps pain but is safer and
has fewer side effects. The information doctors have about how much Ketorolac to give a
child, though, is what has been learned from research in adults. Like with any medication,
the smallest amount that a child can take while still getting pain relief is best and safest.
Why give more medicine and have a higher risk of getting a side effect, if a lower dose will
do the trick? This is what the researchers don't know about Ketorolac and what this study
aims to find out.
Children 6-17 years old who are reporting bad pain when they are in the Emergency Department
or admitted in hospital and who will be getting an intravenous line in their arm will be
included in the study. Those who want to participate will understand that the goal of the
study is to find out if a smaller amount of medicine improves pain as much as a larger
amount. By random chance, like flipping a coin, the child will be placed into a treatment
group. The difference between these treatment groups is the amount of Ketorolac they will
get. One treatment will be the normal dose that doctors use at MCH, and the other two doses
will be smaller. Neither the patient, parent nor doctor will know how much Ketorolac they are
getting. Over two hours, the research nurse or assistant will ask the child how much pain
they are in. Our research team will also measure how much time it took for the pain to get
better, and whether the child had to take any other medicine to help with pain. The research
team will also ask families and patients some questions to understand their perceptions of
pain control, pain medicines and side effects they know of.
This research is important because it may change the way that doctors treat children with
pain, not just at MCH but around the world. The results of this study will be shared with
doctors through conferences and scientific papers. It's also important that clinicians share
information with parents and children so that they can understand more about pain medicines
and how these medicines can be used safely with the lowest chance of side effects.